Proteomics International Pty Ltd

Site

WA Proteomics Facility CHEM

Accreditation No.

16838

Site No.

18237

Date of Accreditation

16 Jul 2009

Address

Harry Perkins Institute of Medical Research, Level 1 QQ Block, QEII Medical Centre, 6 Verdun Street
Nedlands, WA 6009
Australia

proteomics.com.au

Contact

Dr Jason Ito P: +61 (08) 93891992

Availability

Services available to external clients

Scope of Accreditation

Print scopes

ISO/IEC 17025 (2017)

Food and Beverage

Service Product Determinant Technique Procedure
Analysis of physical and nutritional characteristics Liquid milk; Milk concentrates; Milk powder; Milk protein concentrate; Milk protein isolate A2 milk protein HPLC  A2 Protein Determination in Client Supplied Milk Samples (0-36)

ISO/IEC 17025 (2017)

Healthcare, Pharmaceutical and Media Products

Service Product Determinant Technique Procedure
Analysis for physical and chemical characteristics of human and veterinary medicines including vaccines Liquid pharmaceutical preparations; Solid pharmaceutical preparations Physiochemical tests - Proteins Chromatography; Gel electrophoresis; HPLC; LC-MS; MALDI-TOF; UV-vis spectrophotometry Protein ID (001)
De Novo Seq (002)
Proteome mapping (003)
1-D Gel Electrophoresis (004)
Phosphorylation Detection (007)
Intact Mass Analysis (008)
N-terminal Sequencing (010)
Disulfide Bridge (011)
N-Glycan analysis
Isoelectric focusing (IEF)
UV Vis/Fluorescent spectral analysis
Analytical HPLC for
     Charge variant Analysis by WCX,
     Hydrophobic Interaction Chromatography (HIC)
     Size exclusion (SEC)
Biological analysis of other healthcare or pharmaceutical products and accessories Biological or environmental sample containing protein; Protein derivative and small molecule (<900 Daltons) in liquid and solid format Concentration; Differential biomarker identification; Physicochemical tests Chromatography; Electrophoresis; HPLC; LC-MS; MALDI-TOF; Mass spectrometry (MS)
Protein ID (001)
De Novo Seq (002)
Proteome mapping (003)
1-D Gel Electrophoresis (004)
Phosphorylation Detection (007)
Intact Mass Analysis (008)
N-terminal Sequencing (010)
Disulfide Bridge (011)
N-Glycan analysis
Isoelectric focusing (IEF)
UV Vis/Fluorescent spectral analysis
Analytical HPLC for
     Charge variant Analysis by WCX,
     Hydrophobic Interaction Chromatography (HIC)
     Size exclusion (SEC)
Pharmacokinetic monitoring (014)
Proteome Quantitation (iTRAQ/TMT) (005)
Targeted Analysis MRM/SRM (006)
Molecular analysis - Bioinformatic analysis and interpretation Biological or environmental sample containing protein; Liquid pharmaceutical preparations; Protein derivative; Small molecules (<900 Daltons) in liquid and solid format; Solid pharmaceutical preparations Concentration; Data annotation and interpretation; Physicochemical tests - Proteins and small molecules; Tertiary analysis - Data annotation and interpretation; Tertiary analysis - Differential biomarker identification; Tertiary analysis - Physiochemical tests Chromatography; Electrophoresis; HPLC; LC-MS; MALDI-TOF; Mass spectrometry (MS); UV-vis spectrophotometry Protein ID (001)
De Novo Seq (002)
Proteome mapping (003)
1-D Gel Electrophoresis (004)
Phosphorylation Detection (007)
Intact Mass Analysis (008)
N-terminal Sequencing (010)
Disulfide Bridge (011)
N-Glycan analysis
Isoelectric focusing (IEF)
UV Vis/Fluorescent spectral analysis
Analytical HPLC for
-Charge variant Analysis by WCX,
-Hydrophobic Interaction Chromatography (HIC) and
-Size exclusion (SEC)
Pharmacokinetic monitoring (014)
Proteome quantitation (TRAQ/TMT) (005)
Targeted Analysis MRM/SRM (006)

The only data displayed is that deemed relevant and necessary for the clear description of the activities and services covered by the scope of accreditation.

Grey text appearing in a SoA is additional freetext providing further refinement or information on the data in the preceding line entry.